Fructosamine: A Negative Acute Phase Reactant-Reference-Cited by-同舟云学术

Fructosamine: A Negative Acute Phase Reactant

Published:2017-05-31 Issue:1 Volume:12 Page:234-235
ISSN:1932-2968
Container-title:Journal of Diabetes Science and Technology
language:en
Short-container-title:J Diabetes Sci Technol

Author:

Garman Elizabeth¹,Chadburn Andrew J.¹,Abbas Raad²,Modupe Anu¹,Thomas Osmond L.²,Chugh Sanjiv²,Deshpande Shreeram²,Ford Clare¹,Gama Rousseau¹³

Affiliation:

1. Departments of Clinical Chemistry, New Cross Hospital, Wolverhampton, West Midlands, UK

2. Departments of Orthopaedics, New Cross Hospital, Wolverhampton, West Midlands, UK

3. Research Institute, Healthcare Sciences, Wolverhampton University, Wolverhampton, West Midlands, UK

Publisher

SAGE Publications

Subject

Biomedical Engineering,Bioengineering,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/1932296817712527

Reference5 articles.

1. Advantages and Pitfalls of Fructosamine and Glycated Albumin in the Diagnosis and Treatment of Diabetes

2. World Health Organization. Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. WHO/NMH/CHP/CPM/11.1. Geneva, Switzerland: World Health Organization; 2011.

3. Effect of the systemic inflammatory response, as provoked by elective orthopaedic surgery, on HbA1c

4. The impact of acute illness on HbA1cdetermination of undiagnosed diabetes

5. Effect of Fluctuations in Albumin on Serum Fructosamine Assay

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of Fructosamine 3-kinase and Glyoxalase 1 activity in normal and breast cancer tissues;BioMedicine;2021-08-25

2. Diabetes mellitus in chronic kidney disease: Biomarkers beyond HbA1c to estimate glycemic control and diabetes-dependent morbidity and mortality;Journal of Diabetes and its Complications;2020-11

3. From Bench to Bedside: Doing No Harm Is Sweet;Clinical Orthopaedics & Related Research;2020-02-24

4. Glycated serum proteins: High in pancreatic cancer and low in preeclampsia;Progress in Molecular Biology and Translational Science;2019